Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma
Title
Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma
Creator
Burgei J; Dasgupta R; Kim I; Makkar H
Publisher
American Journal of Respiratory and Critical Care Medicine
Date
2019
2019
Description
Thematic Poster Session, ATS Conference 2019. Presented as part of session A39: Drug Related Case Reports
Subject
Respiratory System; General & Internal Medicine
Identifier
https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1489
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
URL Address
https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1489
Search for Full-text
Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home
Pages
2
Volume
199
ISSN
1073-449X
Citation
Burgei J; Dasgupta R; Kim I; Makkar H, “Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma,” NEOMED Bibliography Database, accessed April 20, 2024, https://neomed.omeka.net/items/show/6421.